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Abstract 
Background and purpose: Studies demonstrate that free radicals are involved in the pathogenesis of diabetic 
complications. The aim of this study was to determine the implication of total antioxidant capacity (TAC) and some 
enzymatic and non-enzymatic antioxidants as suitable biomarkers of diabetic complications risk factors.
Methods: A total of 90 patients (70 patients with or without diabetic complications +20 normal healthy) were exam-
ined by evaluating the level of lipid peroxidation, nitrogen monoxide (NO), fasting blood glucose, glycated haemoglo-
bin (HbA1c), enzymatic and non-enzymatic antioxidants using standard spectrophotometric methods.
Results: The fasting blood glucose and HbA1c levels were respectively 2.05 and 2.32 times higher in the group of 
patients with diabetes and complications (DPWC) compared to those of healthy persons. A statistically higher level of 
malondialdehyde (MDA), NO and TAC was observed in a group of patients with diabetes and complications com-
pared to those without complications (DPNC). A significant positive correlation was found between catalase (CAT) 
and fasting blood glucose while a significant and negative correlation was noted between reduced glutathione (GSH) 
and fasting blood glucose. Also was noted a significant relationship between HbA1c and other markers of oxidative 
stress.
Conclusions: The results suggest that the plasma levels of CAT, TAC and reduced glutathione could give information 
on the risk of developing complications of diabetes, considering that the modification of these biomarkers levels were 
associated with oxidative stress.
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Background
Diabetes in all their forms are characterised by either a 
hyperglycemia or a relative or absolute lack of insulin 
action. Type 2 diabetes mellitus (DM) has similar physio-
pathological characteristics with type 1 DM but differs 
in etiology [1]. As an endocrinological disease diabetes 
is associated with several metabolic alterations includ-
ing hyperglycemia and high level of oxidative stress. The 
later plays an important role in the development of dia-
betes complications both in the microvascular and car-
diovascular systems [1]. Oxygen free radical generated 
from glycosylation, auto-oxidation of glycation prod-
ucts, changes of the tissue content and/or the activity of 
the antioxidant defence systems are some mechanisms 
involved oxidative stress in diabetics patients [2]. Free 
radicals not trapped by anti-oxidants during the period of 
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oxidative stress are known to disturb endothelial depend-
ent vasorelaxation, stimulate growth factors, induce the 
expression of adhesion molecules, promote blood coag-
ulation and contribute to the formation of advanced 
glycosylation end products [3]. Several by-products of 
lipid peroxidation found in a higher level in the serum 
of patients with diabetes, have been correlated with the 
development of complications of diabetes [4, 6]. Reactive 
oxygen species (ROS) have been involved in the induc-
tion oxidative damage of several macromolecules includ-
ing lipids, nucleic acids and proteins in patients with 
diabetes [7]. Most of these side effects can be prevented 
by antioxidants [8, 9]. Several studies have provided evi-
dences of oxidative damage of different macromolecules 
and their impact on antioxidant/pro-oxidant systems in 
type 2 diabetic patients. A number of antioxidants exists 
in the cells either enzymatic (superoxide dismutase, glu-
tathione peroxidase and catalase) or non-enzymatic (as 
glutathione and uric) as scavengers of ROS, to prevent 
oxidative damage of biological membranes [7, 10, 11]. 
Beside these antioxidants found in the cells, natural anti-
oxidants exist from vegetables and most of them includ-
ing vitamin A, vitamin C, vitamin E and carotenoids. 
To improve our knowledge on the pathogenesis of some 
metabolic diseases, several clinical and experimental 
studies have been undertaken in order to understand the 
role of the oxidative stress in the pathogenesis of diabetes 
[3, 5]. These investigations have described that free radi-
cals generated during this oxidative process is involved in 
genesis of diabetes, plays significant role in its develop-
ment of diabetes and complications [1, 4, 7, 12–15]. In 
such a context, it appears important to evaluate the level 
of oxidative stress parameters in blood as biomarkers that 
can be used to identify and prevent the risk of promoting 
diabetic complications. Up till now, the methods used to 
detect the status of oxidative stress in patients at clinical 
level are scarce in literature. Although some useful meth-
ods are available to investigate the oxidative profile, they 
are unfortunately not applicable for clinical diagnosis. 
However, some of these methods can be used to better 
understand the appearance of complications that occur 
during the development of some metabolic diseases such 
as diabetes. In this light, it seems important to associate 
the blood levels of TAC, GSH and fasting blood glucose 
in order to understand what happens in patients with 
type 2 diabetes with complications compared to healthy 
persons. The measure of antioxidant capacity consid-
ers the cumulative action of all the antioxidants present 
in plasma and body fluids, thus providing an integrated 
parameter rather than the simple sum of the measurable 
antioxidants. The capacity of the known and unknown 
antioxidants and their synergistic interaction is therefore 
assessed, thus giving an insight into the delicate balance 
in vivo between oxidants and antioxidants. In this study 
serum levels of enzymatic and non-enzymatic antioxi-
dant markers were determined in three groups of persons 
(healthy persons, diabetic patients without complica-
tions (DPNC) and diabetic patients with complications 
(DPWC) and discussed the relationships between these 
markers.
Population of study
A total of 70 patients with type 2 diabetes (40 diabetic 
patients without complications (DPNC) and 30 diabetic 
patients with complications (DPWC) and 20 healthy per-
sons (as controls) were recruited. These diabetic patients 
with/without complications were regularly followed up 
at the Diabetology and Obesity Unit of the Central Hos-
pital of Yaoundé. Participants who accepted to take part 
in the study were recruited on a consecutive basis and 
enrolled after completing and signing the standardised 
data collection forms which included socio-demographic 
characteristics and medical history. We included in the 
study, patients who had the following criteria for DPNC: 
age ranging between 30 and 90  years old with glycated 
haemoglobin (HbA1c)  >6.2% of total Hb; fasting blood 
glucose comprised between 0.8 and 1.2 g/l; post prandial 
glycemia lower than 2  g/l. The abstaining participants 
who were diagnosed or whose medical history revealed 
the presence of glaucoma, cataracts, retinopathy; neu-
ropathy, nephropathy, hypertension, hyperlipidemia and 
ketoses were classified among DPWC. The two groups 
of diabetic patients were treated with insulin (hormono-
therapy) or drugs glucose-lowering effects such as sulfo-
nylureas, biguanides.
These patients were matched age and sex wise with 
healthy persons without diabetes. All diabetic patients 
and healthy people affected with other disease or under 
medication which can affect oxidative stress markers 
were excluded in our study. Lifestyle, habits and previ-
ous medical records were collected from each subject. 
The control group of subjects was made of healthy vol-
unteers recruited either at the University or in different 
families. A written informed consent, approved by the 
National Ethical Committee was obtained for all subjects 
(Reference: CBI/231/ERCC/CAMBIN-Protocole No 024, 
29th/11/2013).
Availability of data and materials
We obtained the consent to publish the data from the 
participants reporting individual patient’s data.
Methods
Samples collection
From each fasted individual who accepted to participate 
to the study and signed the consent form, venous blood 
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samples were collected into two different tubes, a sodium 
fluoride plain and an EDTA coated tubes. Samples con-
tained in plain tubes were stored for 30  min at 4  °C 
prior to centrifugation at 3000  rpm for 5  min to obtain 
the serum samples which were stored at −20  °C. These 
serum samples were subsequently used to determine 
antioxidant and pro-oxidant parameters. The samples 
contained in EDTA coated tubes were used to determine 
the glycated hemoglobin (HbA1c ≥  6.2 0%) and plasma 
glucose concentration.
Determination of pro‑oxidant markers
The fasting blood glucose and glycated hemoglobin were 
determined with commercial kits (Human, Germany). 
Malondialdehyde (MDA), an end product of unsaturated 
fatty acid peroxidation can react with thiobarbituric acid 
(TBA) to form a colored complex called thiobarbitu-
ric acid-reactive substances (TBARS) [16]. Results were 
expressed in µmol per mg of protein.
The nitrogen monoxide (NO) concentration in the 
serum was measured using the Griess’ reaction, by add-
ing 100  µl of Griess’ reagents (0.1% naphthylethylendi-
amide dihydrochloride in H2O and 1% sulfanilamide in 
5% concentrated H3PO4; vol. 1:1) to 100  µl of samples. 
The optical density at 550  nm was then obtained in a 
spectrophotometer. The nitrite levels were calculated by 
using sodium nitrite as a standard and expressed as in 
µmol [17].
Measurement of antioxidant markers
The total antioxidant capacity (TAC) was determined by 
the Ferric Reducing Ability of Plasma (FRAP) method 
in which a colourless ferric tripyridyltriazine complex is 
reduced to a blue ferrous complex by the antioxidants 
in the serum. Briefly, a mixed solution of 50 µl of serum 
and 50 µl of distilled water was added to 900 µl of FRAP 
reagent and incubated at 37  °C for 25  min. The change 
in absorbance at 593  nm is directly related to the total 
reducing power of electron donating antioxidants present 
in the serum [18]. The results were expressed in µmol per 
mg of protein.
The reduced glutathione level was determined by the 
Ellman’s method [19]. This method was based on the 
development of yellow colour when 5,5′-dithio-bis-
2-nitrobenzoic (DTNB) is added to compound contain-
ing sulphydryl groups. The colour developed was read at 
412 nm in the spectrophotometer. Results were expressed 
as µmol/mg protein.
The superoxide dismutase (SOD) activity of the serum 
was determined according to the method described by 
Misra and Fridovich [20]. The method is based on the 
inhibition of epinephrine auto-oxidation. The absorbance 
was read at 480 nm against a blank and the SOD activity 
was expressed as U/mg of protein.
The activity of serum CAT was determined according 
to the method described by Sinha [21]. The results were 
expressed as U/mg of protein.
Statistical analysis
The results obtained were presented as mean ± SEM. The 
analysis of data was conducted using Kruskal–wallis test 
and Dunnett’s multiple test (SPSS program version 18.0). 
The software Graph Pad Instat 3 was used to achieve the 
correlation between the groups. The differences were 
considered as significant at P < 0.05.
Results
The characteristics of all the population involved in this 
study are shown in Table  1. Among all the participants 
in the different groups, men were more represented than 
women with a sex ratio of 1.09. However this value varied 
from 1.10 to 1.5 depending on the group of patients. The 
age of the patients was between 30 and 90 years with an 
average of 54 ± 3 years. The most represented age group 
was between [40 and 60] for healthy people (75%) and 
DPNC (60%) and between [50 and 70] for DPWC (73%). 
Among the risk factors studied, alcohol consumption was 
the most represented either in healthy people or patients 
with diabetes with/without complications. The complica-
tions mostly found in the DPWC were ocular disorders 
(46.6%) and stroke (26.6%) (Fig. 1).
Variation of clinical parameters
Glycated hemoglobin and fasting blood glucose levels 
determined to assess the glycemic status of patients are 
represented in Table  2. These results show a significant 
Table 1 Characteristics of the sample population









 Male 60 52.5 53.3
 Female 40 47.5 46.66
Age
 30< age <40 5 10 3.33
 40< age <50 40 27.5 16.66
 50< age <60 35 32.5 36.66
 60< age <70 10 20 36.66
 >70 10 10 6.66
Smoking 0 5 23.33
Alcohol 60 32.5 76.66
Family history 50 25 53.33
Hypertension 5 20 36.66
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increase in glycosylated hemoglobin and blood glucose 
in diabetic patients with/without complications com-
pared to healthy persons. HbA1c and fasting blood glu-
cose levels of diabetic patients with complications are 
respectively 2.05 and 2.32 times higher compared to 
those of healthy persons. No significant change in BMI 
in patients of different groups while lipid peroxidation 
index increased from healthy patients to DPWC.
Variation of stress oxidative markers
The results of this study showed the changes in both oxi-
dant and antioxidant statuses of patients. As shown in 
Table 3, the mean value of SOD activity was higher and 
significant in the control group compared to the group of 
patients with diabetes. This value decreased significantly 
from DPNC to DPWC with the respective values of 0.38 
to 0.24 U/mg of protein. Similar results were noted with 
CAT activity. However, the CAT activity of the con-
trol group was significantly lower compared to that of 
patients with diabetes (Table 3). The results of the total 
antioxidant capacity decreased significantly (P  <  0.05) 
from the healthy persons (210.48 µmol/mg of protein) to 
DPWC (171.35 µmol/mg of protein). However, no signifi-
cant difference was observed between DPNC and DPWC 
groups. MDA is a low molecular weight aldehyde that can 
be produced from free radical attack on polyunsaturated 
fatty acids of biological membranes and the determina-
tion of this marker is used for monitoring lipid peroxi-
dation in biological samples. Serum MDA and nitrite 
levels as well as lipid peroxidation index (LPI) were sig-
nificantly higher in diabetic patients with and without 
complications indicating the free radical mediated oxi-
dative damage of lipids. The concentration of TAC and 
NO were significantly higher in a group of DPWC who 
smoke and drink alcohol compared to DPNC (Table 4). A 
significant and negative relationship was noted between 
fasting glucose and glutathione in DPNC while a signifi-
cant and positive correlation was observed between fast-

















Fig. 1 Different complications found on DPVC
Table 2 Variation of clinical parameters
Results are expressed as mean ± SD, Values subscripted with different letters are significantly different in the same line
DPNC diabetic patients without complications, DPWC diabetic patients with complications, BMI body mass index, In the same column, values subscripted with 
different letter are significantly different
Control (mean ± SD) N = 20 DPNC (mean ± SD) N = 40 DPWC (mean ± SD) N = 30 P value
HbA1C (%) 4.75 ± 0.11a 8.20 ± 0.44b 9.73 ± 0.52c P < 0.05
Fasting blood glucose (g/l) 1.15 ± 0.05a 2.11 ± 0.13b 2.67 ± 0.17c P < 0.05
BMI (kg m2) 29.03 ± 5.23a 27.20 ± 5.28a 25.92 ± 5.78a P > 0.05
Table 3 Variation of oxidant and antioxidant parameters
Results are expressed as mean ± SD
DPNP diabetic patients without complications, DPWC diabetic patients with complications, LPI lipid peroxidation index, MDA malondialdehyde, CAT catalase, SOD: 
superoxide dismutase, GSH reduced glutathione, NO2 nitrite oxide
* P < 0.05 significant compare with the control
Control (mean ± SD) N = 20 DPNC (mean ± SD) N = 40 DPWC (mean ± SD) N = 30
MDA (µmol/mg of protein) 0.28 ± 0.03 0.29 ± 0.02 0.32 ± 0.03
NO2
− (µmol) 191.41 ± 11.54 216.07 ± 8.96 227.38 ± 10.15
TAC (µmol/mg of protein) 210.48 ± 6.22 160.46 ± 7.65* 171.35 ± 6.43*
CAT (U/mg of protein) 28.34 ± 2.67 37.37 ± 1.78* 35.19 ± 2.37*
SOD (U/mg of protein) 0.41 ± 0.04 0.38 ± 0.03* 0.24 ± 0.01*
GSH (µM/mg of protein) 6.77 ± 0.59 9.78 ± 0.58* 9.79 ± 0.73*
LPI (MDA/TAC) 0.180 0.181 0.186
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in DPWC and healthy people (Table 5). Moreover, a sig-
nificant and positive relationship was also noted between 
HbA1c, NO, MDA and GSH while the negative and sig-
nificant correlation was noted between HbA1c and TAC 
demonstrating that oxidative stress may affect HbA1c.
Discussion
Diabetes does not only alter the metabolism of carbo-
hydrates, lipids and protein, but also the chemistry of 
these macromolecules. Poorly controlled diabetes accel-
erates the chemical modification of proteins and their 
functions which could lead to the development of dia-
betic complications. In this context, several hypotheses 
have been emitted in order to understand the origin of 
the complications observed in diabetic patients. These 
hypotheses include mitochondria damage, mitochon-
drial defect in oxidative phosphorylation, increased for-
mation of advanced glycation end products (AGES), 
increased activity of the polyol pathway, hypoxia, altera-
tion of lipoprotein metabolism, increased protein kinase 
C activity, alteration of growth factors and cytokine, 
activities and increased oxidative and reductive stress 
[15, 22]. Although oxidative stress appears as one of the 
metabolic events associated to diabetes and its complica-
tions the precise mechanisms by which oxidative stress 
may accelerate the development these complications are 
still not well understood [7]. Oxidative stress seems to be 
increased in a system where the rate of free radicals pro-
duction is increased and/or the antioxidant mechanisms 
are impaired [22].
The present study examined the variation in both 
extra and intracellular antioxidants, oxidant status, fat-
ing blood glucose as well as HbA1c in a group of diabetic 
patients without or with complications. The glycated 
hemoglobin (HbA1c fraction) which estimates the fast-
ing blood glucose over a period of three months is useful 
and considered as a reference parameter in monitor-
ing glycemic control in diabetic patients. Our results 
showed the increase in fasting blood glucose and HbA1c 
levels in a group of diabetic patients with complications 
(DPWC) compared to those without complications and 
healthy persons. Indeed hyperglycemia causes tissue 
damage through 5 major mechanisms: (1) increased flux 
of glucose and other sugars through the polyol pathway; 
(2) increased intracellular formation of AGEs (advanced 
glycation end products); (3) increased expression of the 
receptor for AGEs and its activating ligands; (4) acti-
vation of protein kinase C (PKC) isoforms and (5) the 
over activity of the hexosamine pathway [13]. Previ-
ous studies have shown that an increase in glucose lev-
els induces diabetes, the overproduction of oxygen free 
radicals which consequently increases the protein and 
lipid oxidation. Malondiadehyde (MDA) is highly toxic 
by-products partly produced by oxidation and derived 
from lipid. MDA reacts both irreversibly and reversibly 
with proteins and phospholipids with profound effects. 
In this study, high statistical significant differences were 
observed in the levels of MDA in these cases. MDA was 
higher in the case of DPNC and DPWC groups than in 
the control group. Similar results were found in previous 
studies [23, 24]. The observed high levels of plasma MDA 
in diabetic patients reflect lipid peroxidation which is the 
consequence of oxidative stress. The increase in the level 
of MDA correlates with hyperglycemia in these patients 
because of self-oxidation of glucose and could generate 
free radicals. A significant correlation exists between 
the biomarkers of oxidative stress and fasting blood 
glucose in DPWC and DPNC. Our study demonstrated 
Table 4 Comparison of  oxidant and  antioxidant param-
eters of alcohol and smoking patients
DPNP diabetic patients without complications, DPWC diabetic patients with 







 SOD (U/mg of 
protein)
0.4190 ± 0.2484 0.2347 ± 0.07693 0.0314
 TAC (µmol/mg of 
protein)
141.93 ± 57.322 184.00 ± 42.294 0.0327
Smoking
 NO2 (µM) 199.60 ± 67.633 244.86 ± 16.249 0.0345
Table 5 Correlation between antioxidant and clinical parameters in different groups of patients
DPNP diabetic patients without complications, DPWC diabetic patients with complications, CAT catalase, TAC total antioxidant capacity, NO Nitrite oxide
P < 0.05 is significant
Control N = 20 DPNC N = 40 DPWC N = 30
r2 P value r2 P value r2 P value
Fasting blood glucose and CAT 0.252 0.285 −0.151 0.340 0.460 0.011
Fasting blood glucose and glutathione 0.134 0.573 −0.540 0.001 0.025 0.897
TAC and glutathione 0.563 0.010 0.122 0.440 −0.059 0.758
HbA1 and NO 0.392 0.04 0.76 0.003 0.123 0.004
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a significant positive correlation between fasting blood 
glucose and CAT activity while significant negative asso-
ciation was demonstrated between fasting blood glucose 
and glutathione. Nitrogen monoxide (NO) is an impor-
tant vascular target for ROS. Ion Superoxide, NO and 
the peroxynitrite formed are sources of hydroxyl radi-
cals that could cause endothelial damage [2]. Increased 
levels of NO observed in DPNC and DPWC compared 
to healthy patients could be explained by the fact that 
hyperglycemia in diabetic patients affects the vascular 
endothelium and the associated vascular tone by affect-
ing NO levels. In the diabetic state, the endothelium is 
exposed to high concentrations of glucose and this likely 
leads to some of the vascular abnormalities which result 
due to glucose toxicity. The endothelial dysfunction 
associated with diabetes has been attributed to lack of 
bioavailable NO due to reduced ability to synthesise NO 
from l-arginine [25]. NO is a candidate for mediating 
hyper filtration and the increased vascular permeabil-
ity induced by diabetes. The higher level of NO in these 
groups correlates with the reduction of total antioxidant 
capacity. The reduction of the total antioxidant capac-
ity in the presence of higher levels of lipid peroxidation 
in serum of patients with type 2 diabetes indicates the 
existence of oxidative stress. The significant correlation 
between HbA1c and serum with NO content found in 
the present study confirms that hyperglycemia control 
may directly influence NO synthesis. It is well known 
that the expression of NO action largely depends on 
its relative level and on its interaction with superoxide 
anions. These results support the findings that vascu-
lar dysfunction due to exposure to pathologically high 
d-glucose concentrations may be caused by impair-
ment of the NO pathway and increased oxidative stress 
accompanied by altered glucose metabolism.
The synergistic effect of antioxidants in human plasma 
is known to provide greater protection against free radi-
cal aggression than any single antioxidant alone. In addi-
tion to the total antioxidant capacity (TAC), the enzyme 
antioxidant activities to trap the free radicals generated 
under normal or pathological conditions were evaluated 
by measuring SOD, CAT and reduced glutathione level. 
The high concentration of superoxide dismutase causes 
impairment of endothelial isoform of nitrogen monoxide 
synthase (eNOS) by triggering advanced glycation end 
products and poly (ADP-ribose) polymerase [26].
Reduced glutathione (GSH), a non-enzymatic antioxi-
dant plays an excellent role by protecting cells from oxi-
dative damage keeping up the cellular levels of the active 
forms of vitamins C and E by neutralizing the free radi-
cals. The increase in the GSH level in DPNC and DPWC 
may be related to increase activity of glutathione peroxi-
dase which acts by neutralizing free radicals produced 
during the complication of the disease. This extracellular 
non-enzymatic antioxidant delays or inhibits the oxida-
tive process through different mechanisms. Antioxidant 
enzyme levels are particularly sensitive to oxidative stress 
and both increase or decrease these have been reported 
in different disease states in which an enhancement of 
oxygen species is a cause or a consequence of the disease 
[7]. The significant variation in CAT and SOD activities in 
the serum of diabetic patients with and without compli-
cations was also noted. The increase in CAT activity may 
be a respond to an induction of the enzyme caused by the 
high level of its substrate (organoperoxides and H2O2) 
[24]. This observation may results in a number of delete-
rious effects due to the accumulation of superoxide radi-
cals and hydrogen peroxides [27]. Our results confirm 
that diabetes, alcohol and smoking are associated with an 
increase of oxidative stress, which results in higher serum 
concentration MDA and nitrogen monoxide radical or in 
lower level of SOD activity in DPWC group. To the best 
of our knowledge very few studies demonstrated these 
findings. However, it has been reported that excessive use 
of alcohol can contribute to increase BMI [27, 28]. Our 
results of SOD and CAT indicate a relationship between 
these two enzymes which may play an important role in 
the effective control of oxidative stress without the vari-
ation of one or the other being sufficient independently 
[7]. The ratio CAT/SOD is considered to be a biomarker 
of the glycemic control while the MDA/FRAP ratio is a 
biomarker of lipid peroxidation [7, 28]. These two ratios 
are considered as the risk factors for the development 
of diabetes complications. Increase in lipid peroxidation 
products (as indicated by the level of MDA) due to the 
decrease activity of most of the antioxidant enzymes is in 
line with previous reports [24, 29]. Hence complications 
of diabetes may be the result of this high level of free 
radicals (increase in the level of MDA and peroxidation 
index) and the reduction in antioxidant defences (SOD 
and total antioxidant capacity). This study provides evi-
dence of oxidative damage of different molecules and its 
impact on antioxidant/pro-oxidant system in type 2 dia-
betic patients with or without complications.
Conclusion
Our studies showed that the levels of fasting blood glu-
cose and HbA1c, MD and NO were higher in a group of 
diabetic patients compare the control group. Except for 
SOD, HbA1c and fasting blood glucose, there was no sig-
nificant difference between the two groups of diabetic 
patients. The increase of fasting blood glucose affected 
the levels of reduced glutathione and catalase in the 
group of diabetic patient. The correlation between dif-
ferent markers can provide additional information on the 
risk of diabetic complications.
Page 7 of 7Pieme et al. BMC Res Notes  (2017) 10:141 
Abbreviations
BMI: body mass index; CAT: catalase; DM: diabetes mellitus; DPNC: group of 
diabetic patients without complications; DTNB: 5,5′- dithio-bis-2-nitrobenzoic; 
DPWC: group of diabetic patients with complications; EDTA: ethylene diamine 
tretra acetic acid; GSH: reduced glutathione; MDA: malondialdehyde; NO: 
nitrgen monoxide; H3PO4: phosphoric Acid; eNOS: nitric oxide synthase; ROS: 
reactive oxygen species; SOD: superoxide dismutase; TAC: total antioxi-
dant capacity; TBA: thiobarbituric acid; TBARS: thiobarbituric acid-reactive 
substances.
Authors’ contributions
TJA, MMB and TNF conducted the study, PCA and SG designed and supervised 
the study, AMVJ and SE helped for selecting, recruitment of patients and 
graciously have offered kits for HbA1C and glycaemia determination, BNPC 
and NNBL carried out the analysis of data. PCA prepared the manuscript. All 
authors read and approved the final manuscript.
Author details
1 Department of Biochemistry and Physiological Sciences; Faculty of Medicine 
and Biomedical Sciences, University of Yaounde I, P.O. Box 1364, Yaounde, 
Cameroon. 2 Department of Biochemistry, Faculty of Science, University 
of Dschang, P.O. Box 67, Dschang, Cameroon. 3 Department of Biochemistry, 
Faculty of Science, University of Yaounde I, P.O. Box 812, Yaounde, Cameroon. 
4 Department of Internal Medicine, Faculty of Medicine and Biomedical Sci-
ences, University of Yaoundé I, P.O. Box 1364, Yaounde, Cameroon. 
Acknowledgements
The authors are grateful to the staff and all the diabetic patients of Diabetol-
ogy and Obesity Unit of the Central Hospital of Yaoundé.
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
The data sets used and/or analyzed during the current study are available 
from the corresponding author on reasonable request.
Ethics approval and consent to participate
A written informed consent, approved by the Cameroon National Ethical 
Committee was obtained from all candidates. This research was approved by 
the Cameroon Bioethics Initiative (CAMBIN) under the following reference: 
CBI/231/ERCC/CAMBIN-Protocole No 024, 29th/11/2013.
Received: 17 June 2016   Accepted: 21 March 2017
References
 1. Osman E, Levent K, Nuriye U, Nazife K, Baysa K, Ruhan K, Naciye Y. Cor-
relations of serum Cu+2, Zn+2, Mg+2 and HbA1c in type 2 and type 2 
diabetes mellitus. Turkish J. Endocrinol Metabol. 2004;2:75–9.
 2. Ramakrishna V, Jailkhani R. Evaluation of oxidative stress in insulin 
dependent diabetes mellitus (IDDM) patients. Diagn Pathol. 2007;2(22):1–
6. doi:10.1186/1746-1596-2-22.
 3. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular 
complications. Diabetes Care. 1996;19:257–67.
 4. Maritim AC, Sanders RA, Watkins JB III. Diabetes, oxidative stress and 
antioxidants: a review. J Biochem Mol Toxicol. 2003;17:24–38.
 5. Guillermo Z, Fortuño A, Díez J. Oxidative stress and atherosclerosis in 
early chronic kidney disease. Nephrol Dial Transpl. 2006;21:2686–90.
 6. Liu Shang X, Hou Fan F, Guo Zhi J, Nagai R, Zhang Wei R, Liu Zhi Q, Zhou 
Zhan M, Zhou M, Di X, Wang Guo B, Zhang X. Advanced oxidation protein 
products accelerate atherosclerosis through promoting oxidative stress 
and inflammation. Arterioscler Thromb Vasc Biol. 2006;26:1156–62.
 7. Martinez-Sanchez G, Popov I, Perez-Davison G, Al-Dalaen S, Horwat-
Delaporte R, Giuliani A, Leon-Fernandez OS. Contribution to charac-
terization of oxidative stress in diabetic patients with macroangiopatic 
complications. Acta Farm Bonaerense. 2005;24(2):197.
 8. Vaziri ND. Pathogenesis of lead-induced hypertension: role of oxidative 
stress. Am J Hypert. 2002;20:15–20.
 9. Lim CS, Vaziri ND. The effects of iron dextran on the oxidative stress 
in cardiovascular tissues of rats with chronic renal failure. Kidney Int. 
2004;65:1802–9.
 10. Heistad DD. Oxidative stress and vascular disease. Arterioscler Thromb 
Vasc Biol. 2005;26:689–95.
 11. Engler MM, Engler MB, Malloy MJ, Chiu EY, Schloetter MC, Paul SM, Stue-
hlinger M, Lin KY, Cooke JP, Morrow JD, Ridker PM, Rifai N, Miller E, Witz-
tum JL, Mietus-Snyder M. Antioxidant vitamins C and E improve endothe-
lial function in children with hyperlipidemia: endothelial assessment of 
risk from lipids in youth (EARLY) Trial. Circulation. 2003;108:1059–63.
 12. Zhou XJ, Vaziri ND, Wang XQ, Silva FG, Laszik Z. Nitric oxide synthase 
expression in hypertension induced by inhibition of glutathione syn-
thase. J Pharmacol Exp Therap. 2002;300:762–7.
 13. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ 
Res. 2010;107(9):1058–70. doi:10.1161/CIRCRESAHA.110.223545.
 14. Jamuna Rani A, Mythili SV, Shunmugam N. Serum nitrite levels in relation 
to malondialdehydein type 2 diabetes mellitus: a pilot study. Recent Res 
Sci Technol. 2012;4(6):11–2.
 15. Oliveira AC, Teixeira CJ, Stefanello TF, Carrara MA, Bazotte RB, Sá-Nakanishi 
AB, Comar JF, Batista MR. Oxidative stress parameters as biomarkers of 
risk factor for diabetic foot among the patients with type 2 diabetes. Braz 
Arch Biol Technol. 2014;57(2):223–7.
 16. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by 
a new colorimetric method. Clin Chem Acta. 1978;90(1):37–43.
 17. Mathew G, Glenda J, Jack L. Quantitation of nitrite and nitrate in extracel-
lular fluids. Met Enzymol. 1996;268:237–46.
 18. Benzie F, Strain J. The ferric reducing ability of plasma (FRAP) as a measure 
of ‘‘Antioxidant Power’’: the FRAP assay. Anal Bioch. 1996;239:70–6.
 19. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82:70.
 20. Misra H, Fridovich I. Estimation of superoxide dismutase. J Biochem. 
1972;247:3170–8.
 21. Sinha KA. Colorimetric assay of catalase. Anal Biochem. 1972;47:389–94.
 22. Arya AK, Pokharia D, Tripathi K. Relationship between oxidative stress and 
apoptotic markers in lymphocytes of diabetic patients with chronic non 
healing wound. Diabetes Res Clin Pract. 2011;94(3):377–84.
 23. Mahreen R, Mohsin M, Nasreen Z, Siraj M, Ishaq M. Significantly increased 
levels of serum malonaldehyde in type 2 diabetics with myocardial infarc-
tion. Int J Diabetes in Dev Ctries. 2010;30:49–51.
 24. Okoduwa SIR, Umar A, Ibrahim S, Bel F. Relationship of oxidative stress 
with type 2 diabetes and hypertension. J Diabetol. 2013;1:1–10.
 25. Amrita G, Mingma LS, Yazum B, Ranabir P, Sanjay D. Serum nitric oxide 
status in patients with type 2 diabetes mellitus in Sikkim. Int J Appl Basic 
Med Res. 2011;1(1):31–5. doi:10.4103/2229-516X.81977.
 26. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu 
Rev Med. 1995;46:223–34.
 27. Sozmen EY, Sozmen B, Delen Y, Onat T. Catalase/superoxide dismutase 
(SOD) and catalase/paraoxonase (PON) ratios may implicate poor glyce-
mic control. Arch Med Res. 2001;32:283–7.
 28. American Association of Clinical Endocrinologists. (AACE): hypertension 
guidelines. Endocr Pract. 2006;12:193–222.
 29. Kumawat M, Pahwa MB, Gahlaut VS, Singh N. Status of antioxidant 
enzymes and lipid peroxidation in type 2 diabetes mellitus with micro-
vascular complications. Open End J. 2009;3:13–6.
